Literature DB >> 9535863

A modular DNA carrier protein based on the structure of diphtheria toxin mediates target cell-specific gene delivery.

C Uherek1, J Fominaya, W Wels.   

Abstract

Modular fusion proteins that combine distinct functions required for cell type-specific uptake and intracellular delivery of DNA present an attractive approach for the development of self-assembling vectors for targeted gene delivery. Here, we describe a novel DNA carrier protein termed GD5 that mimics the structure of the bacterial diphtheria toxin (DT) and facilitates target cell-specific gene transfer via receptor-mediated endocytosis. GD5 carries at the N terminus the DNA-binding domain of the yeast transcription factor Gal4, which is connected to a C-terminal antibody fragment specific for the tumor-associated ErbB2 antigen via an internal DT translocation domain as an endosome escape activity. Bacterially expressed GD5 protein specifically bound to ErbB2-expressing cells and formed protein-DNA complexes with a luciferase reporter gene construct. These complexes, after compensation of excess negative charge with poly-L-lysine, served as a specific transfection vector for ErbB2-expressing cells. Inhibitors of endosomal acidification drastically reduced GD5-mediated transfection, indicating that the DT translocation domain of GD5, similar to the parental toxin, is strictly dependent on the transit through an acidic environment. Our results suggest that fusion proteins that employ the natural endosome escape mechanism of bacterial toxins might aid in the development of efficient nonviral vectors for applications in gene therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535863     DOI: 10.1074/jbc.273.15.8835

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Strategies to improve drug delivery across the blood-brain barrier.

Authors:  Albertus G de Boer; Pieter J Gaillard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

2.  Bioreducible polymers with cell penetrating and endosome buffering functionality for gene delivery systems.

Authors:  Tae-il Kim; Thomas Rothmund; Thomas Kissel; Sung Wan Kim
Journal:  J Control Release       Date:  2011-02-23       Impact factor: 9.776

Review 3.  The potential for gene therapy in pancreatic cancer.

Authors:  M J Humphreys; W Greenhalf; J P Neoptolemos; P Ghaneh
Journal:  Int J Pancreatol       Date:  1999-08

4.  Effective delivery of antisense peptide nucleic acid oligomers into cells by anthrax protective antigen.

Authors:  Daniel G Wright; Ying Zhang; John R Murphy
Journal:  Biochem Biophys Res Commun       Date:  2008-09-05       Impact factor: 3.575

5.  Distinct effects of endosomal escape and inhibition of endosomal trafficking on gene delivery via electrotransfection.

Authors:  Lisa D Cervia; Chun-Chi Chang; Liangli Wang; Fan Yuan
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

Review 6.  Engineered biological entities for drug delivery and gene therapy protein nanoparticles.

Authors:  Joan Domingo-Espín; Ugutz Unzueta; Paolo Saccardo; Escarlata Rodríguez-Carmona; José Luís Corchero; Esther Vázquez; Neus Ferrer-Miralles
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

Review 7.  Novel modular transporters delivering anticancer drugs and foreign DNA to the nuclei of target cancer cells.

Authors:  A S Sobolev
Journal:  J BUON       Date:  2009-09       Impact factor: 2.533

8.  Nuclear localization signals in phage terminal proteins provide a novel gene delivery tool in mammalian cells.

Authors:  Modesto Redrejo-Rodríguez; Daniel Muñoz-Espín; Isabel Holguera; Mario Mencía; Margarita Salas
Journal:  Commun Integr Biol       Date:  2013-03-01

9.  Targeting of Synthetic Gene Delivery Systems.

Authors:  Andreas G. Schätzlein
Journal:  J Biomed Biotechnol       Date:  2003

Review 10.  Drug Delivery with Polymeric Nanocarriers-Cellular Uptake Mechanisms.

Authors:  Levi Collin Nelemans; Leonid Gurevich
Journal:  Materials (Basel)       Date:  2020-01-13       Impact factor: 3.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.